Trifluoroacetate → 2-(4-Fluorophenyl)-4-(piperazin-1-ylmethyl)oxazole TFA Salt
Reaction equation
[F:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[O:9][CH:10]=[C:11]([CH2:13][N:14]3[CH2:19][CH2:18][N:17](C(OC(C)(C)C)=O)[CH2:16][CH2:15]3)[N:12]=2)=[CH:4][CH:3]=1.[F:27][C:28]([F:33])([F:32])[C:29]([O-:31])=[O:30]>>[OH:31][C:29]([C:28]([F:33])([F:32])[F:27])=[O:30].[F:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[O:9][CH:10]=[C:11]([CH2:13][N:14]3[CH2:15][CH2:16][NH:17][CH2:18][CH2:19]3)[N:12]=2)=[CH:4][CH:3]=1Participants
3
Procedure
This compound was synthesized from tert-butyl 4-((2-(4-fluorophenyl)oxazol-4-yl)methyl)piperazine-1-carboxylate as described for example 46 step 4 (130 mg, crude) as a trifluoroacetate salt and it was carried through without further purification. 1H NMR (400 MHz, DMSO-d6) δ 8.67 (br s, 2H), 8.21 (s, 1H), 8.04-8.01 (m, 2H), 7.42-7.38 (t, J=8.9 Hz, 2H), 3.80 (m, 2H), 3.18 (m, 4H), 2.88 (m, 4H). MS (ESI) m/z: Calculated for C14H16FN3O: 261.13. found: 262.0 (M+H)+
Workup
- customwas carried through without further purification
Sources & evidence
- ORD record
- ord-2c0b8ae634a64ec998ed3b225d61811c
- Source dataset
- uspto-grants-2015_03
- Patent number
- US08981084B2
Reaction notes
Loading…